We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01113281
First Posted: April 29, 2010
Last Update Posted: November 21, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Farmovs-Parexel Bloemfontein, Republic of South Africa (Clinical Site)
Triclinium Johannesburg, RSA (Monitoring and Overall Management of the study)
University of Stellenbosch
HJ-CTC George, RSA (Statistics & Report)
Information provided by (Responsible Party):
Vakzine Projekt Management GmbH
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)